Logo image of SNTI

SENTI BIOSCIENCES INC (SNTI) Stock Price, Quote, News and Overview

NASDAQ:SNTI - Nasdaq - US81726A2096 - Common Stock - Currency: USD

2.13  -0.19 (-8.19%)

After market: 2.8701 +0.74 (+34.75%)

SNTI Quote, Performance and Key Statistics

SENTI BIOSCIENCES INC

NASDAQ:SNTI (7/11/2025, 8:00:02 PM)

After market: 2.8701 +0.74 (+34.75%)

2.13

-0.19 (-8.19%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High16.94
52 Week Low1.52
Market Cap55.55M
Shares26.08M
Float11.16M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-13 2025-08-13
IPO05-26 2021-05-26


SNTI short term performance overview.The bars show the price performance of SNTI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

SNTI long term performance overview.The bars show the price performance of SNTI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SNTI is 2.13 USD. In the past month the price decreased by -24.2%. In the past year, price decreased by -33.44%.

SENTI BIOSCIENCES INC / SNTI Daily stock chart

SNTI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.74 339.94B
AMGN AMGEN INC 14.22 158.77B
GILD GILEAD SCIENCES INC 14.17 136.38B
VRTX VERTEX PHARMACEUTICALS INC N/A 120.40B
REGN REGENERON PHARMACEUTICALS 12.81 61.30B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 41.07B
ARGX ARGENX SE - ADR 97.43 34.21B
BNTX BIONTECH SE-ADR N/A 27.14B
ONC BEONE MEDICINES LTD-ADR 6.4 27.09B
NTRA NATERA INC N/A 21.91B
BIIB BIOGEN INC 8.48 19.67B
INSM INSMED INC N/A 18.63B

About SNTI

Company Profile

SNTI logo image Senti Biosciences, Inc. is a biotechnology company. The company is headquartered in South San Francisco, California and currently employs 34 full-time employees. The company went IPO on 2021-05-26. The firm is leveraging its synthetic biology platform to engineer gene circuits into new medicines with enhanced precision and control. These gene circuits are designed to kill cancer cells, to spare healthy cells, to increase specificity to target tissues, and/or to be controllable even after administration. Its product candidates include SENTI-202 and SENTI-301A. SENTI-202 is a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural killer (CAR-NK) investigational cell therapy. SENTI-301A is a multi-armed off-the-shelf healthy donor-derived chimeric antigen receptor natural killer (CAR-NK) cell therapy product candidate designed for the treatment of GPC3 positive tumors.

Company Info

SENTI BIOSCIENCES INC

2 Corporate Drive, First Floor

South San Francisco CALIFORNIA US

Employees: 48

SNTI Company Website

SNTI Investor Relations

Phone: 16502392030

SENTI BIOSCIENCES INC / SNTI FAQ

What is the stock price of SENTI BIOSCIENCES INC today?

The current stock price of SNTI is 2.13 USD. The price decreased by -8.19% in the last trading session.


What is the ticker symbol for SENTI BIOSCIENCES INC stock?

The exchange symbol of SENTI BIOSCIENCES INC is SNTI and it is listed on the Nasdaq exchange.


On which exchange is SNTI stock listed?

SNTI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for SENTI BIOSCIENCES INC stock?

8 analysts have analysed SNTI and the average price target is 12.24 USD. This implies a price increase of 474.65% is expected in the next year compared to the current price of 2.13. Check the SENTI BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SENTI BIOSCIENCES INC worth?

SENTI BIOSCIENCES INC (SNTI) has a market capitalization of 55.55M USD. This makes SNTI a Micro Cap stock.


How many employees does SENTI BIOSCIENCES INC have?

SENTI BIOSCIENCES INC (SNTI) currently has 48 employees.


What are the support and resistance levels for SENTI BIOSCIENCES INC (SNTI) stock?

SENTI BIOSCIENCES INC (SNTI) has a support level at 2.12 and a resistance level at 2.36. Check the full technical report for a detailed analysis of SNTI support and resistance levels.


Is SENTI BIOSCIENCES INC (SNTI) expected to grow?

The Revenue of SENTI BIOSCIENCES INC (SNTI) is expected to decline by -28.57% in the next year. Check the estimates tab for more information on the SNTI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SENTI BIOSCIENCES INC (SNTI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SENTI BIOSCIENCES INC (SNTI) stock pay dividends?

SNTI does not pay a dividend.


When does SENTI BIOSCIENCES INC (SNTI) report earnings?

SENTI BIOSCIENCES INC (SNTI) will report earnings on 2025-08-13.


What is the Price/Earnings (PE) ratio of SENTI BIOSCIENCES INC (SNTI)?

SENTI BIOSCIENCES INC (SNTI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.54).


What is the Short Interest ratio of SENTI BIOSCIENCES INC (SNTI) stock?

The outstanding short interest for SENTI BIOSCIENCES INC (SNTI) is 3.56% of its float. Check the ownership tab for more information on the SNTI short interest.


SNTI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SNTI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SNTI. The financial health of SNTI is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNTI Financial Highlights

Over the last trailing twelve months SNTI reported a non-GAAP Earnings per Share(EPS) of -11.54. The EPS decreased by -115.47% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -53.95%
ROE -104.01%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%96.87%
Sales Q2Q%N/A
EPS 1Y (TTM)-115.47%
Revenue 1Y (TTM)-100%

SNTI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to SNTI. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 83.91% and a revenue growth -28.57% for SNTI


Ownership
Inst Owners28.21%
Ins Owners0.85%
Short Float %3.56%
Short Ratio1.16
Analysts
Analysts82.5
Price Target12.24 (474.65%)
EPS Next Y83.91%
Revenue Next Year-28.57%